Gateway Investment Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-43,183
Closed -$7.13M 541
2021
Q2
$7.13M Sell
43,183
-17,248
-29% -$2.88M 0.07% 199
2021
Q1
$9.27M Hold
60,431
0.1% 172
2020
Q4
$7.58M Sell
60,431
-26
-0% -$2.91K 0.08% 197
2020
Q3
$6.13M Sell
60,457
-151
-0.2% -$15.4K 0.07% 200
2020
Q2
$5.9M Sell
60,608
-307
-0.5% -$28.6K 0.07% 212
2020
Q1
$5.06M Buy
60,915
+29,220
+92% +$2.85M 0.06% 215
2019
Q4
$3.52M Sell
31,695
-8,957
-22% -$921K 0.03% 298
2019
Q3
$4.03M Sell
40,652
-100
-0.2% -$9.93K 0.04% 293
2019
Q2
$4.04M Buy
40,752
+22,942
+129% +$2.19M 0.04% 295
2019
Q1
$1.96M Buy
17,810
+194
+1% +$20.3K 0.02% 364
2018
Q4
$1.62M Buy
+17,616
New +$1.78M 0.02% 391

Other funds holding PRAH

Gateway Investment Advisers's PRAH Position: Q3 2021 in Review

Gateway Investment Advisers sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 43,183 shares — an estimated $7.13M sold.

Gateway Investment Advisers first reported a position in PRAH in Q4 2018 and held it in 11 quarters. The position peaked at $9.27M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Gateway Investment Advisers reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Gateway Investment Advisers sold 43,183 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $7.13M.
  • Gateway Investment Advisers first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 11 quarters.
  • Gateway Investment Advisers's PRA Health Sciences, Inc. position peaked at $9.27M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Gateway Investment Advisers's 13F filing for Q3 2021, filed 22 Oct 2021.